Ständer, S, Pereira, MP, Zeidler, C, Legat, FJ, Misery, L, Loenndahl, L, Bewley, AP, Brenaut, E, Bobko, S, Elberling, J, Evers, AWM, Garcovich, S, Gieler, U, Goncalo, M, Kupfer, J, Lambert, J, Lvov, A, Metz, M, Michenko, A, Papadavid, E, Reich, A, Savk, E, Schneider, G, Schut, C, Serra-Baldrich, E, Ständer, HF, Szepietowski, JC, Wallengren, J, Weisshaar, E, Augustin, M. EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(9)DOI:10.1111/jdv.20102. PMID:38738586. IF:8.000(Q1/1D).

Silverberg, JI, Bieber, T, Paller, A, Beck, LA, Kamata, M, Puig, L, Wiseman, M, Ezzedine, K, Foley, P, Johansson, E, Dossenbach, M, Akmaz, B, Casillas, M, Karlsson, A, Chovatiya, R. Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis. BRITISH JOURNAL OF DERMATOLOGY. 2024; 191DOI:10.1093/bjd/ljae266.014. PMID:. IF:9.600(Q1/1D).

Bissonnette, R, Warren, RB, Pinter, A, Agner, T, Gooderham, M, Schuttelaar, MLA, Crépy, MN, Stingeni, L, Serra-Baldrich, E, Baranowski, K, Korn, S, Kurvits, M, Plohberger, U, Vest, NS, Schliemann, S. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, trials. LANCET. 2024; 404(10451)DOI:10.1016/S0140-6736(24)01027-4. PMID:39033766. IF:88.500(Q1/1D).

Puig, L, Fujita, H, Thaçi, D, Zheng, M, Daly, ACH, Leonardi, C, Lebwohl, MG, Barker, J. Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search. Dermatology and Therapy. 2024; 14(9)DOI:10.1007/s13555-024-01230-z. PMID:39088126. IF:4.200(Q1/1D).

Butrón-Bris, B, Llamas-Velasco, M, Ovejero-Benito, MC, Santos-Juanes, J, Martínez-López, A, Ruiz-Villaverde, R, Roustan, G, Baniandrés, O, Izu-Belloso, R, de la Cueva, P, Sahuquillo-Torralba, A, Gónzalez-Quesada, A, Vilarrasa-Rull, E, Pujol-Montcusi, J, García-Martínez, J, Navares, M, Palomar-Moreno, I, Novalbos, J, Abad-Santos, F, Daudén, E, de la Fuente, H. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice. EXPERIMENTAL DERMATOLOGY. 2024; 33(8)DOI:10.1111/exd.15152. PMID:39081053. IF:3.100(Q2/3D).

Rusinol, L, Puig, L. A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158437. PMID:39126010. IF:4.900(Q1/3D).